Literature DB >> 30798774

Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients.

Michelle Lycke1,2, Tessa Lefebvre1,2, Lies Pottel1, Hans Pottel3, Lore Ketelaars4, Karin Stellamans5, Koen Van Eygen1,6, Philippe Vergauwe7, Patrick Werbrouck8, Lieselot Cool1, Tom Boterberg2, Nick Liefhooghe5, Patricia Schofield9, Philip R Debruyne1,9.   

Abstract

OBJECTIVES: Cognitive complaints, of objective or subjective nature, may negatively impact cancer patients' quality of life (QoL). Further, the early detection of cognitive alterations may lead to an improved QoL. However, the content of such screening is yet unclear. This paper presents long-term QoL data of cancer patients treated with curative intent and its relation with objective and subjective cognitive complaints, and patient-reported outcome measures (PROMs).
METHODS: QoL data, measured by the EORTC QLQ C-30, were obtained at baseline, 6 (T1), 12 (T2), and 24 months (T3) after treatment start, and compared between patients with and without objective and subjective cognitive complaints. The predictive value of PROMs was also examined.
RESULTS: QoL data at baseline was collected in 125 patients. Response rates at T1, T2, and T3 were 84.7%, 81.5%, and 83.1%, respectively. Eighty-nine patients returned their QoL questionnaires at all times. Baseline subjective cognitive complaints had a stronger association with worse scores on patients' overall QoL and QoL subscale scores than objective cognitive complaints. An exploratory analysis into the value of PROMs in predicting long-term QoL at T3 revealed a significant effect for the Hospital Anxiety and Depression Scale-Depression and FACIT Fatigue scale.
CONCLUSIONS: Self-perceived cognitive alterations are negatively associated with patients' overall QoL. As these troubles may already be present at baseline, oncology nurses should screen for the early signs of subjective cognitive complaints by use of PROMs, in order to refer the patient to proper intervention programs which may lead to an improved long-term QoL and faster reintegration into society.

Entities:  

Keywords:  anxiety/depression; behavioral health; quality of life; quantitative research methods; survivorship

Mesh:

Year:  2019        PMID: 30798774     DOI: 10.1080/07347332.2018.1504154

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  7 in total

Review 1.  Systematic Review of Cognitive Impairment in Colorectal Cancer Survivors Who Received Chemotherapy.

Authors:  Ya-Ning Chan; Ashley Leak Bryant; Jamie L Conklin; Tyra Girdwood; Aaron Piepmeier; Rachel Hirschey
Journal:  Oncol Nurs Forum       Date:  2021-11-01       Impact factor: 2.172

2.  A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON).

Authors:  Laura Tack; Tessa Lefebvre; Michelle Lycke; Chistine Langenaeken; Christel Fontaine; Marleen Borms; Marianne Hanssens; Christel Knops; Kathleen Meryck; Tom Boterberg; Hans Pottel; Patricia Schofield; Philip R Debruyne
Journal:  EClinicalMedicine       Date:  2021-08-19

3.  Longitudinal changes in patient-reported cognitive complaints among older adults with gastrointestinal malignancies - results from the Cancer and Aging Resilience Evaluation (CARE) Registry.

Authors:  Mackenzie E Fowler; Donna Murdaugh; Christian Harmon; Mustafa Al-Obaidi; Noha Sharafeldin; Smita Bhatia; Smith Giri; Grant R Williams
Journal:  J Cancer Surviv       Date:  2022-09-17       Impact factor: 4.062

4.  Reliability and validity of a novel cognitive self-assessment tool for patients with cancer.

Authors:  Giuliana V Zarrella; Alice Perez; Jorg Dietrich; Michael W Parsons
Journal:  Neurooncol Pract       Date:  2021-07-21

5.  Recognition of cognitive complaints for patients with advanced cancer.

Authors:  Denise Pergolizzi; Iris Crespo
Journal:  Support Care Cancer       Date:  2020-08-11       Impact factor: 3.603

6.  Long-term employment status and the association with fatigue in patients with grade II glioma.

Authors:  Ellen M P van Loon; Willemijn Ernens; Majanka H Heijenbrok-Kal; Herwin L D Horemans; Gerard M Ribbers; Martin J van den Bent
Journal:  J Rehabil Med       Date:  2021-05-28       Impact factor: 2.912

7.  Mastication, swallowing, and salivary flow in patients with head and neck cancer: objective tests versus patient-reported outcomes.

Authors:  Jorine A Vermaire; Cornelis P J Raaijmakers; Irma M Verdonck-de Leeuw; Femke Jansen; C René Leemans; Chris H J Terhaard; Caroline M Speksnijder
Journal:  Support Care Cancer       Date:  2021-06-25       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.